Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Antithrombin III Deficiency; Pre-Eclampsia Phase 4 ClinicalTrials
Heart Diseases Phase 1 ClinicalTrials
Antithrombin III Deficiency Phase 2 ClinicalTrials
Fibrosis; Liver Cirrhosis; Thrombosis; Venous Thrombosis Phase 1 ClinicalTrials
Acute Coronary Syndrome; Aortic Valve Insufficiency; Aortic Valve Stenosis; Constriction, Pathologic; Mitral Valve Insufficiency; Mitral Valve Stenosis Phase 4 ClinicalTrials
CONTENTS